Hernán-Darío-Quiceno-Arias

Hernan Dario Quiceno Arias

Médico Especialista
Specialty:
Pathology
Serving specialties:
  • Anatomía Patológica
Hospitals where he/she works:
  • Hospital Universitario Fundación Jiménez Díaz
Consultation: Pathology Department FJD
Opening times: De 08:00 a 15:00
General Information
Experience
  • Assistant Pathologist, Jimenez Diaz Foundation University Hospital, 2015 to present.
  • Assistant Pathologist , la Luz Hospital , 2016-2023
  • Residency , Clinic University of Navarra, 2011-2015.
Degree
  • Medical Degree, University of Antioquia/Medellín, Colombia.
  • Specialist in Pathology, Clinic University of Navarra/Pamplona, Spain.
  • MSc in Molecular Oncology , University Rey Juan Carlos/Madrid, Spain.
Insurance companies
Techniques
  • Gastrointestinal Pathology and Endocrine Pathology
  • Frozen Section Pathology
Research and teaching

Research:

  • PI20/00487 Title: Inflammation as a Therapeutic Target in Type II Diabetes Complications. Role: Collaborating Researcher
  • -PI23/00119. Title: The Role of Inflammation in the Prevention of Type 2 Diabetes and Its Complications: Modulating Inflammatory Signaling Pathways as Adjunct Therapy to New Antidiabetic Drugs Role: Collaborating Researcher
  • - PI23/01070 Title: Role and Regulation of Protein Phosphatase 2A Activity in Cholangiocarcinoma: Impact on Prognosis and Prediction of Drug Response Role: Collaborating Researcher

Teaching:

  • Clinical Assistant Professor of Anatomic Pathology
Publications

- Bernal S, Prieto I, Kavanagh M, Del Real IH, La Manna S, Lázaro I, Quiceno H, López-Sanz L, Picatoste B, Valdecantos MP, Mas-Fontao S, Sala-Vila A, Valverde ÁM, Marasco D, Egido J, Gómez-Guerrero C. Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease. Redox Biol. 2025 May 11;84:103670. doi: 10.1016/j.redox.2025.103670. Epub ahead of print. PMID: 40373621.

- Sánchez MM, Domínguez-Prieto V, Qian Zhang S, Quiceno Arias HD, Álvarez Álvarez MB, Fuertes MJ, Meliga C, Jiménez-Galanes S, Labajo HG, Olmo DG, Campos PV. Inflammatory Fibroid Polyp (Vanek's Tumor): A Retrospective Multicentric Analysis of 67 Cases. Cancers (Basel). 2025 Apr 2;17(7):1209. doi: 10.3390/cancers17071209. PMID: 40227778; PMCID: PMC11987972.
- Soto-Catalán M, Opazo-Ríos L, Quiceno H, et al. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease. Int J Mol Sci. 2024;25(5):2961. Published 2024 Mar 4. doi:10.3390/ijms25052961
-Gonzalez RS, Pastrián LG, Pyatibrat S, Arias HDQ, Gil YR, Booth AL, de la Peña Navarro I, Garmendia-Irizar M, Lapointe JR, Mobarki M, Nova-Camacho LM, Parini G, Romio E, Alayza AR, Pritt BS, Ruz-Caracuel I. Submucosal Necrotic Nodule of the Colon: An Enigmatic Entity Potentially Related to Anisakis Infection. Arch Pathol Lab Med. 2023 Nov 1;147(11):1315-1319. doi: 10.5858/arpa.2022-0267-OA. PMID: 36656170.
-Paja M, Zafón C, Iglesias C, Ugalde A, Cameselle-Teijeiro JM, Rodríguez-Carnero G, Fernández-Seara P, Anda E, Povoa A, Quiceno H, Sánchez-Gómez NM, González C, García-Pascual L, Gómez de la Riva I, Blanco C, Meizoso T, Riesco-Eizaguirre G, Capel I, Ortega MV, Mancha I, Chao M, Alcázar V, Roselló E, Maravall J, López-Agulló S, Pérez-Lázaro A, Meseguer P, Sanz J, Paricio JJ, Echeverría S, Castaño Á, Bella RM. Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist's criteria: a multicentre retrospective Southern European study with prolonged follow-up. Endocrine. 2021 Jul;73(1):131-140. doi: 10.1007/s12020-021-02610-7. Epub 2021 Jan 23. PMID: 33484411.
-Ramírez-Bellver JL, Macías E, Bernárdez C, López-Robles J, Vegas-Sánchez MD, Díaz-Recuero JL, Quiceno H, Requena L. Anti-NXP2-Positive Paraneoplastic Dermatomyositis With Histopathologic Changes Confined to the Acrosyringia. Am J Dermatopathol. 2017 Jan;39(1):e3-e7. doi: 10.1097/DAD.0000000000000694. PMID: 28045754.

Communications and Presentations
  • -Pathological Response after Neoadjuvant Multikinase Inhibitors in Thyroid Carcinoma: Where Are We Now? XXXII National Congress of SEAP-IAP, San Sebastián, May 21-23, 2025.
  • -Gastrointestinal Changes Secondary to Immunotherapy. XXXII National Congress of SEAP-IAP, San Sebastián, May 21-23, 2025.
  • -Therapeutic Selection through Biomarkers in Thyroid Carcinoma. XXXII National Congress of SEAP-IAP, San Sebastián, May 21-23, 2025.
  • -Inflammatory Bowel Disease-Like Lesion. SEAP, I Ibero-American Pathological Anatomy Conference, May 16-17, 2024, Mahón, Menorca.
  • -Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE). Endocrine Pathology Working Group Meeting, SEAP, November 2023, Sabadell, Catalonia.
  • -Thyroid Metastasis of Clear Cell Renal Carcinoma. XXIX National Congress of SEAP-IAP ,May 2019, Granada.
Awards and certifications
  • - ARETÉ Scholarship 2025 awarded by Jimenez Diaz Foundation University Hospital
  • - Spanish Association Against Cancer (AECC) Training Grant for clinical professionals.